Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c991
Identifier NCT05722353
Trial Title IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima®
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions OTHER: Biocollection
Participant Information
Sponsor Assistance Publique - Hôpitaux de Paris
City Paris
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2023-02-13
Primary Completion Date 2025-11
Completion Date 2025-11